
A potential rush of treatment options on the horizon for non-alcoholic steatohepatitis will require skillful maneuvering in this likely lucrative but uncharted therapeutic market.
Jayachandra Reddy has an extensive pharmaceutical background, covering strategic consulting and commercial analytics. Rishit Thakkar is a professional with over 10 years' experience in Research and Analytics. Jayachandra is a Senior Director at phamax, where Rishit also works as a Senior Project Manager. phamax is a dedicated research platform for scientific and analytical market access solutions.
A potential rush of treatment options on the horizon for non-alcoholic steatohepatitis will require skillful maneuvering in this likely lucrative but uncharted therapeutic market.
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Published: October 3rd 2017 | Updated:
Published: November 1st 2017 | Updated: